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ABSTRACT
Bordetella bronchiseptica and B. pertussis are Gram-negative bacteria that cause respiratory diseases in animals and humans.
The current incidence of whooping cough or pertussis caused by B. pertussis has reached levels not observed since the
1950s. Although pertussis is traditionally known as an acute childhood disease, it has recently resurged in vaccinated
adolescents and adults. These individuals often become silent carriers, facilitating bacterial circulation and transmission.
Similarly, vaccinated and non-vaccinated animals continue to be carriers of B. bronchiseptica and shed bacteria resulting in
disease outbreaks. The persistence mechanisms of these bacteria remain poorly characterized. It has been proposed that
adoption of a biofilm lifestyle allows persistent colonization of the mammalian respiratory tract. The history of Bordetella
biofilm research is only a decade long and there is no single review article that has exclusively focused on this area.
We systematically discuss the role of Bordetella factors in biofilm development in vitro and in the mouse respiratory tract.
We further outline the implications of biofilms to bacterial persistence and transmission in humans and for the design
of new acellular pertussis vaccines.
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INTRODUCTION
Whooping cough or pertussis is increasing steadily in the USA
and other developed countries, leading the CDC to classify
pertussis as a reemerging disease (CDC 2012; Cherry 2012;
Jakinovich and Sood 2014). As a reflection of this resurgence,
in 2015, pertussis and its causative organism Bordetella pertus-
siswere included in the emerging infectious diseases/pathogens
list maintained by the National Institute of Allergy and
Infectious Diseases (http://www.niaid.nih.gov/topics/pertussis/
Pages/research.aspx). Despite widespread immunization in
childhood, 50 million cases and 300 000 deaths due to per-
tussis are estimated globally each year. Historically, pertussis
has been perceived as a disease affecting non- or underim-
munized infants. It is classically characterized by a series of
short paroxysmal coughs followed by a vigorous inspiratory ef-
fort resulting in the whooping sound. In recent years, an in-
crease in the incidence of pertussis has been observed in ado-
lescents and adults with acquired immunity from vaccinations
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or previous infection (Cherry 2012, 2014). These individuals gen-
erally display milder symptoms often resembling viral respi-
ratory infections and lack the characteristic ‘whoop’. Pertus-
sis in adolescents and adults often results in loss of time from
school or work, social isolation, sleep deficiency or anxiety about
an undiagnosed condition (McLaughlin et al. 2015). These in-
dividuals are now recognized as a major source of transmis-
sion of bacteria residing mainly in the upper respiratory tract
(Cherry 2014).
Bordetella bronchiseptica has a broad host range and causes
a spectrum of diseases in animals. It also infects both im-
munocompromised and healthy humans thereby demonstrat-
ing zoonotic transmission (Mattoo and Cherry 2005; Sukumar
et al. 2014). It is widespread in swine populations and is an
important contributor to respiratory disease in pigs (Zhao et
al. 2011). In dogs, infection with B. bronchiseptica and several
canine viruses can result in infectious tracheobronchitis or
kennel cough (Schulz et al. 2014). In cats, B. bronchiseptica
infection sometimes results in deaths particularly in young
kittens when the disease progresses rapidly to bronchopneu-
monia (Coutts et al. 1996). In addition to causing severe dis-
eases, a hallmark of B. bronchiseptica infections is long-term
to life-long asymptomatic carriage. Carrier animals continue
to shed the organism thereby infecting susceptible animals
(Bemis, Carmichael and Appel 1977; Coutts et al. 1996; Schulz
et al. 2014). In the laboratory, experimental infection of rats,
mice and rabbits results in chronic and asymptomatic coloniza-
tion of the upper respiratory tract (Goodnow 1980; Akerley, Cot-
ter and Miller 1995; Mattoo, Miller and Cotter 2000; Mattoo and
Cherry 2005).
For both Bordetella species, while significant insights have
been obtained regarding the role of different factors in coloniza-
tion of the respiratory tract, modulation and evasion of host im-
mune responses and the control of gene expression (Mooi 2010;
Hewlett et al. 2014), the mechanism by which these bacteria per-
sist in humans and animals is not well characterized. We pro-
posed the hypothesis that the survival and continued persis-
tence of Bordetella spp. in mammals is due to the formation of
biofilms (Sloan et al. 2007; Conover et al. 2010; Serra et al. 2011).
Biofilms are generally defined as multicellular surface-adherent
microbial communities often encased in a self-produced or
host-derived matrix. This mode of growth confers traits associ-
ated with virulence and pathogenesis and resistance to environ-
mental stresses, host defenses and antimicrobial compounds
(Hall-Stoodley and Stoodley 2009; Hobley et al. 2015). Utilizing
several in vitromodels, the mouse model of respiratory infection
andmultiple imaging techniques, microscopic andmacroscopic
multicellular structures of Bordetella were observed on abiotic
surfaces and in the mouse nose and trachea. The propensity of
Bordetella to form biofilms raises fundamental questions regard-
ing the (i) existence of unique biofilm-associated phenotypes;
(ii) mechanisms by which multicellular structures develop;
(iii) factors that contribute to biofilm development; (iv) re-
lationship between biofilms and survival and persistence in
humans and animals. In this review, we describe recent ad-
vances in the understanding of B. pertussis and B. bronchisep-
tica biofilm lifestyle on artificial surfaces and in the mouse
respiratory tract. We focus on the developmental and regu-
latory aspects of biofilm formation as well as key factors in-
volved in this process. Finally, we put forward the proposal
that biofilms formed in the human nasopharynx protect bacte-
ria from host clearance, allow transmission by dispersion and
can explain the failure of vaccines to break the infectious cycle
of B. pertussis.
Figure 1. Cartoon of biofilm development and the roles of different factors in
various stages of Bordetella biofilm formation. Planktonic cells initiate initial sur-
face adhesion followed by formation of a monolayer ultimately giving rise to 3D
structures. In one study, the initial attachment of B. pertussis (Bp) was Bvg depen-
dent (Bosch et al. 2006) whereas in another study (Mishra et al. 2005), this step
was Bvg independent in both Bp and B. bronchiseptica (Bb). Therefore, BvgAS is
indicated to play a role in both the attachment and maturation stages of biofilm
development. Other regulatory mechanisms ((p)ppGpp, c-di-GMP and BpsR) that
control biofilm formation are also indicated. In Bb, flagella and in Bp, FHA pro-
motes initial surface attachment. Bps, eDNA and FHA promote the formation
and stability of macrocolonies and 3D structures. The inhibitory effect of ACT in
Bb biofilm formation is indicated by bar-headed line. Because the precise mech-
anism by which Fim and ACT contribute to biofilm development is unknown,
these factors are included on both sides of the vertical line. The symbol (ques-
tion mark) indicates the unknown role of Fim and ACT in biofilm formation of
B. pertussis.
ROLE OF THE BvgAS SIGNAL TRANSDUCTION
SYSTEM IN BIOFILM FORMATION
The BvgAS signal transduction regulates the expression of genes
encoding surface, membrane, secreted and regulatory proteins
and those involved in bacterial metabolism and physiology.
BvgA and BvgS are members of a group of the two-component
superfamily of regulatory signal-transducing proteins that com-
municate by a four-step His-Asp-His-Asp phosphorelay system.
In response to changes in the concentrations of certain chemi-
cals, temperature or as a result of specific mutations in the BvgS
sensor kinase, BvgAS mediates a transition between multiple
phenotypic phases (Bvg+, Bvgi and Bvg−). In vitro, BvgAS is ac-
tive (Bvg+ phase) when bacteria are grown at 37◦C and in the ab-
sence of modulators. BvgAS is inactive (Bvg− phase) at tempera-
tures lower than 26◦C or in the presence of high concentrations
of modulators. In the Bvg+ phase, Bordetellae are virulent and ex-
press several adhesins and toxins, whereas in the Bvg− phase
they are non-virulent. At low or intermediate concentration of
modulators, bacteria are in the Bvgi phase, which is character-
ized by the expression of specific genes like bipA (Deora et al.
2001; Cotter and Jones 2003; Deora 2004). Given the importance
and the extensive characterization of BvgAS and its regulated
gene products in Bordetella pathogenesis, it was not surprising
that the first two published studies documenting biofilm forma-
tion by Bordetella showed that BvgAS positively regulated this
phenotype in both B. bronchiseptica (Irie, Mattoo and Yuk 2004;
Mishra et al. 2005) and B. pertussis (Mishra et al. 2005). Compari-
son of the role of BvgAS in different steps of biofilmdevelopment
has resulted in different conclusions. While Mishra et al. (2005)
suggested that biofilm development in both B. bronchiseptica and
B. pertussis was characterized by an initial Bvg-independent at-
tachment stage followed by a Bvg-dependent step that leads
to the development of multicellular biofilms, Bosch et al. (2006)
found both these steps to be Bvg dependent in B. pertussis (Fig. 1).
Differences in experimental protocols and the nature of the
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abiotic surfaces utilized to study biofilms may account for the
observed discrepancies between the two studies.With respect to
the role of different Bvg-regulated phenotypic phases in biofilm
formation, utilizing static assays, maximal biofilm formation
for B. bronchiseptica was reported in the Bvgi phase (Irie, Mattoo
and Yuk 2004; Sisti et al. 2013). However, another study reported
similar levels of biofilm formation when B. bronchiseptica was
grown under static or flow conditions either in the Bvg+ or the
Bvgi phase (Mishra et al. 2005). The role of the Bvgi phase on B.
pertussis biofilm formation is unstudied. In summary, although
published studies from various groups have reached somewhat
different conclusions regarding the role of BvgAS in steps of
biofilm development and the role of specific Bvg-regulated phe-
notypic phases in biofilm formation, it can be concluded that
BvgAS plays an important role in regulating biofilm formation
in both B. bronchiseptica and B. pertussis.
BORDETELLA BIOFILM FORMATION ON
ABIOTIC SURFACES: A HIGHLY REGULATED
DEVELOPMENTAL PROGRAM
In general, bacterial biofilm formation begins with the surface
attachment of the planktonic bacteria resulting in the formation
of a monolayer followed by the formation of aggregates, clus-
ters and microcolonies. Finally, bacteria develop into differenti-
ated structures in which individual bacteria as well as the entire
community are surrounded by an extracellular matrix (Fig. 1)
(Hall-Stoodley and Stoodley 2009). Similarly, biofilm formation
in both B. bronchiseptica and B. pertussis can be microscopically
visualized as a sequential temporal process that is character-
ized by initial surface attachment of bacterial cells, followed by
the formation of a monolayer covering almost the entire sur-
face area (Fig. 2). At this stage, Bordetella biofilms do not dis-
play any 3D structural attributes. At later time points, biofilms
are characterized by cell clusters separated by individual cells
followed by the formation of mature macrocolonies encased
in an opaque matrix-like material (in static systems) (Fig. 2),
pillar-like structures, water channels and or irregularly shaped
microcolonies (in continuous-flow systems) (Parise et al. 2007;
Serra et al. 2008, 2011; Conover et al. 2010; Nicholson, Conover
and Deora 2012). Thus, based on microscopic analyses, Borde-
tella biofilms are highly differentiated communities compared
to their planktonic counterparts and formation of biofilms pro-
ceeds in a stage-specific and coordinated manner (Figs 1 and 2).
This model of Bordetella biofilm development as a sequential
and coordinated process is further supported by gene expression
and proteomic analyses of biofilm cells. Transcriptomic analysis
of B. bronchiseptica biofilms at five different time points repre-
senting distinct biofilm stages revealed that greater than 33% of
the B. bronchiseptica genome undergoes expression changes dur-
ing biofilm growth. Clustering analysis further revealed a cas-
cade of continuous gene expression patterns with orderly tim-
ing of global gene expression lacking sharp transitions. Applica-
tion of clustering analyses to a specific set of genes annotated
to be transcription factors revealed a rigid expression pattern
with specific transcription factors maximally expressed at dis-
tinct biofilm stages (Nicholson, Conover and Deora 2012). In ad-
dition to transcriptomics, independent proteomic analyses in
B. pertussis revealed that about 8% of the cytosolic subproteome
and 10% of the membrane subproteome were found altered in
the biofilm condition (Serra et al. 2008). These findings alongwith
those from other bacteria (Sauer 2003; Petrova and Sauer 2009;
Park et al. 2014) strengthen the concept that bacterial biofilms
are not simply a mixture of planktonic populations at differ-
ent growth stages but represent a true microbial developmen-
tal process that involves large-scale changes in the expression
of biofilm-specific genes and proteins, similar to sporulation by
Bacillus species (Tan and Ramamurthi 2014) and swarmer-to-
stalk cell transition in Caulobacter crescentus (Cornejo, Abreu and
Komeili 2014).
As expected and consistent with the bvg-dependent con-
trol of biofilm formation, transcriptomic analyses also suggested
that in B. bronchiseptica, expression of many of the bvg-activated
genes varied in a temporal manner with the progression of
biofilm formation. Surprisingly, at the initial time points of
biofilm formation, many of the classical bvg-activated genes
were repressed whereas expression of bvg-repressed genes
(those involved in motility and synthesis of flagella) was in-
duced. This suggested that a Bvg− phase phenotype was pre-
ferred during early stages of biofilm formation and suggests a
role for flagella in initial surface contact (Nicholson, Conover and
Deora 2012). The role of flagella in biofilm formation is discussed
later.
ROLE OF BvgAS-REGULATED PROTEIN
FACTORS IN BIOFILM DEVELOPMENT
BvgAS-activated proteins
Bordetella pertussis and B. bronchiseptica produce several Bvg-
activated adhesins namely filamentous hemagglutinin (FHA),
pertactin, fimbriae and BrkA and toxins like adenylate cyclase
toxin (ACT) and pertussis toxin (produced only by B. pertussis).
FHA is a rod-like structure that is both surface-associated and
secreted (Villarino Romero, Osicka and Sebo 2014). Microtiter
plate assays under static conditions showed that both FHA and
fimbriae contribute to biofilm formation in B. bronchiseptica (Irie,
Mattoo and Yuk 2004). The role of FHA in B. pertussis biofilm
Figure 2. Different stages of B. bronchiseptica biofilm development examined by scanning electron microscopy (SEM). At 6 h, initial attachment is evident as individual
cells dispersed in the surface. At 12 h, more cells adhere to the surface showing cell–cell interaction, but without any structural organization. At 24 h, cell clusters are
apparent, evolving in mature macrocolonies enclosed in a self-produced extracellular matrix by 48 h of culture. The figure was taken from Nicholson, Conover and
Deora (2012).
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formation and the mechanisms by which FHA promotes biofilm
formation were later pursued by our groups (Serra et al.
2011). A mutant strain of B. pertussis lacking FHA exhib-
ited reduced surface attachment, decreased biofilm biomass
and did not form microcolonies. Absence of FHA from B.
pertussis, antibody-mediated blockade of surface-associated
FHA and addition of exogenous FHA inhibited the attach-
ment of bacteria to the pre-existing biofilms (Serra et al.
2011). Thus, FHA promotes the structural integrity of B.
pertussis biofilm by mediating cell substrate and interbac-
terial adhesions. The mechanisms by which Fimbriae pro-
mote biofilm formation remain to be determined for both
B. bronchiseptica and B. pertussis.
ACT is a protein toxin produced by both B. pertussis and
B. bronchiseptica (Vojtova, Kamanova and Sebo 2006). It is secreted
by the type I secretion system and remains both surface associ-
ated and released. A B. bronchiseptica strain lacking the cyaA gene
formed higher levels of biofilms than the wild-type strain. It was
proposed that ACT was inhibiting biofilm formation by interact-
ing primarily with FHA (Irie, Mattoo and Yuk 2004). The role of
ACT in B. pertussis biofilm formation and the precise mechanism
of biofilm inhibition remain to be tested.
Role of flagella, a Bvg-repressed surface structure in
biofilm formation
Gene expression profiling of B. bronchiseptica biofilm cells re-
vealed that the expression of genes encoding flagella and motil-
ity, classical Bvg− phase phenotypes occurred early and was
under tight regulatory control (Nicholson, Conover and Deora
2012). By utilizing strains lacking either flaA (encoding the flag-
ellin monomer) or other genes that regulate the production of
flagella, it was shown that flagella were critical for initial sur-
face attachment but were not required for biofilm maturation
(Nicholson, Conover and Deora 2012). While work in other bac-
terial systems suggested that repression of flagellar expression
after the initial attachment is a necessary step for formation of
mature bacterial biofilms (Moorthy and Watnick 2004; Lemon,
Higgins and Kolter 2007), direct experimental evidence for such
a requirement was lacking. By utilizing mutant strains that har-
bored alterations in the regulatory hierarchy of flagella produc-
tion, it was shown that constitutive production of flagella by
B. bronchiseptica results in immature and unstructured biofilms
(Nicholson, Conover and Deora 2012).
The Bordetella biofilm matrix and role of matrix
components in biofilm formation
The bacterial biofilm matrix is composed of several extra-
cellular polymeric substances (EPS) whose composition varies
based on the species. EPS is mainly composed of polysac-
charides, proteins, metabolites and extracellular DNA (eDNA)
(Hall-Stoodley and Stoodley 2009). Bordetella biofilm matrix also
contains polysaccharides, LPS, eDNA and proteins. The sugar
content of the biofilm matrix is composed of xylose (B. bron-
chiseptica), poly-β-1-6-N-acetyl-D-glucosamine (B. bronchiseptica
and B. pertussis) and uronic acids (B. pertussis) (Irie, Preston and
Yuk 2006; Parise et al. 2007; Serra et al. 2008).
eDNA and extracellular polysaccharides also play critical
roles in different aspects of bacterial biofilm formation (Das,
Sehar and Manefield 2013; Payne and Boles 2015). DNase I treat-
ment of B. pertussis and B. bronchiseptica biofilms inhibited biofilm
growth and disrupted established mature biofilms formed un-
der both static and continuous flow conditions, suggesting that
eDNA is involved in maintaining biofilm structure and stability
(Conover, Mishra and Deora 2011). While the detection of several
sugars in the biofilmmatrix suggests a role formanypolysaccha-
rides with distinct biochemical composition in biofilm forma-
tion, Bps remains the only polysaccharide that has been experi-
mentally shown to be required for biofilm formation (Parise et al.
2007; Conover et al. 2010). The bpsABCD operon, which encodes
themachinery for Bps synthesis, is highly conserved in Bordetella
species and is homologous to the pgaABCD locus of Escherichia
coli (Wang, Preston and Romeo 2004) and the icaADBC loci of
Gram-positive bacteria (O’Gara 2007). While the exact biochem-
ical composition of Bps remains to be determined, based on im-
mune reactivity and enzymatic susceptibility to dispersin B, it is
similar in composition to poly-β-(1,6)-N-acetyl-D-glucosamine
type of polysaccharides (Parise et al. 2007; Conover et al. 2010;
Little et al. 2015). In both B. bronchiseptica and B. pertussis, Bps
is dispensable for initial attachment to abiotic surfaces. Instead,
Bps contributes to the stability andmaintenance of the complex
architecture of biofilms (Parise et al. 2007; Conover et al. 2010).
Additional mechanisms of biofilm regulation
In B. bronchiseptica, expression of the bpsA-D locus was elevated
in biofilms (Conover et al. 2012). While, the inducing signals and
control mechanisms of Bps synthesis have not yet been com-
pletely defined, the expression of the bpsA-D locus in B. bron-
chiseptica was not regulated by BvgAS (Conover et al. 2012). A
DNA-binding repressor protein BpsR that negatively regulated
Bps expression and synthesis was identified in B. bronchiseptica.
The absence of BpsR from B. bronchiseptica increased expression
and production of Bps, enhanced biofilm formation and pro-
duced more structured biofilms (Conover et al. 2012). The func-
tion of BpsR is not known in B. pertussis. Continued research
on the role of Bps and BpsR in biofilm formation and regula-
tory mechanisms will further elucidate biofilm developmental
processes.
The signaling molecule bis-(30–50)-cyclic-dimeric guanosine
monophosphate c-di-GMP plays a key role in the decision be-
tween planktonic or biofilm growth, where low intracellular lev-
els of c-di-GMP lead to a planktonic phenotype and high con-
centrations lead to a biofilm phenotype. c-di-GMP is produced
from two GTP molecules by enzymes that contain GGDEF do-
mains, and is degraded by enzymes with EAL or HD-GYP do-
mains (Romling, Galperin and Gomelsky 2013). Overexpression
of Pseudomonas aeruginosa genes that encode enzymes involved
in either the production or degradation of c-di-GMP led to mod-
est but statistically significant enhancement or reduction, re-
spectively in biofilm levels of B. bronchiseptica (Sisti et al. 2013).
Plasmid-mediated expression of a B. bronchiseptica gene encod-
ing a potential diguanylate cyclase increased biofilm forma-
tion in B. bronchiseptica and complemented the biofilm defective
phenotype of a P. fluorescens strain lacking the genes encoding
four diguanylate cyclase proteins (Sisti et al. 2013). Similar to
B. bronchiseptica, a mutant strain lacking the gene encoding for
a diguanylate cyclase displayed reduced biofilm formation in B.
pertussis (Wan et al. 2009). It has been proposed that this pro-
tein synthesizes c-di-GMP and therefore may influence biofilm
formation by sensing O2 tension (Wan et al. 2009). Bordetella bron-
chiseptica encodes four hypothetical proteins with EAL domains,
ten with GGDEF domain and five with both domains (Sisti et al.
2013). Similarly, B. pertussis encodes five proteins with GGDEF
domain and four with EAL domains (Wan et al. 2009). The pres-
ence of several genes encoding proteins with either GGDEF or
EAL domains in the genomes of B. bronchiseptica and B. pertus-
sis suggests the existence of multigene control on the levels of
c-di-GMP and biofilm formation.
Cattelan et al. 5
Figure 3. Bordetella pertussis biofilms and the role of FHA in biofilm formation in the mouse respiratory tract. Groups of 6-week-old C57BL/6 mice were intranasally
inoculatedwith 5 × 105 CFUs of either theWT or 1fhaB strain. Sections of trachea and nasal septumwere harvested at 1 or 7 days post-infection, immediately fixed, and
probed with rat anti-Bordetella serum followed by a donkey anti-rat secondary antibody conjugated to Alexa Flour 488 (stains bacteria green). Respiratory epithelium
was visualized by staining for F-actin using phalloidin conjugated to Alexa Fluor 633 (red staining). For detailed figure legend and the experimental procedure, please
see Serra et al. (2011).
The other regulatory molecule involved in B. pertussis
biofilm formation is the alarmone (p)ppGpp. This molecule
regulates stringent responses and processes important for
bacterial growth, stress survival and virulence (Gaca, Colomer-
Winter and Lemos 2015). A mutant strain of B. pertussis defi-
cient in the production of (p)ppGpp was impaired in autoaggre-
gation and biofilm formation. It was proposed that the effect of
(p)ppGpp on biofilms was mediated by changes in filamentous
structures, since compared to the wild-type strain, the mutant
strain resulted predominantly in short filaments (Sugisaki et al.
2013). Thus, although the intricacies of the various controls on
Bordetella biofilm formation remain unknown, it is clear that Bor-
detella utilizes multiple regulatory mechanisms to maintain a
sessile lifestyle.
BORDETELLA BIOFILM LIFESTYLE IN THE
MAMMALIAN RESPIRATORY TRACT
Despite thewealth of data on themechanisms bywhich bacteria
form biofilms on abiotic surfaces, limited information is avail-
able on factors and mechanisms that contribute to biofilm for-
mation in vivo. Parsek and Singh proposed several criteria to de-
fine biofilm infections, whichwere later revised by Hall-Stoodley
and Stoodley. In essence, these criteria are that (i) infecting bac-
teria should be adherent or attached to the surface, (ii) bacte-
rial microcolonies or aggregates encased in an extracellular ma-
trix either of bacterial or host origin should be directly observed;
(iii) infection should be localized to a particular anatomical
site; (iv) bacteria should be recalcitrant to antibiotic treat-
ment compared to planktonic counterparts, or bacterial clus-
ters/macrocolonies should be localized in host tissues as ev-
idence of ineffective host clearance (Parsek and Singh 2003;
Hall-Stoodley and Stoodley 2009). Utilizing well-established in-
tranasal mouse models of B. bronchiseptica and B. pertussis in-
fections (Harvill, Cotter and Miller 1999; Carbonetti et al. 2005;
Sukumar et al. 2010), a biofilm mode of existence for these
bacteria was demonstrated in the mouse nose and trachea
(Sloan et al. 2007; Conover et al. 2010; Serra et al. 2011). In
both of these models, distinct architectural features (in the
form of mats, towers or pillars separated by void spaces for
B. bronchiseptica and clusters and macrocolonies for B. pertus-
sis; Fig. 3) adherent to ciliated epithelium of the nose and tra-
chea were observed. These surface-adherent biofilms colocal-
ized with Bps (Sloan et al. 2007; Conover et al. 2010). Ex vivo
treatment with DNase I considerably dissolved both B. pertussis
and B. bronchiseptica biofilms formed on the nasal septum, sug-
gesting that eDNA is an additional biofilm matrix component
and contributes to the structural stability of respiratory tract
biofilms (Conover, Mishra and Deora 2011). Bordetella bronchisep-
tica biofilms formed in vitro are as much as 1000-fold more re-
sistant to antibiotics compared to their planktonic counterparts
(Mishra et al. 2005). Respiratory tract biofilms of B. bronchisep-
tica have been visualized as long as 38 days post-inoculation
(Sloan et al. 2007) suggesting that biofilm formation supports
bacterial persistence in the respiratory tract. It has not yet been
experimentally demonstrated that B. pertussis biofilms enhance
antimicrobial resistance. However, respiratory tract biofilms of
B. pertussis have been observed 19 days post-inoculation of bac-
teria (Conover et al. 2010) and mutants of B. pertussis (1fhaB and
1bpsABCD) defective in attachment to epithelial cells, cell–cell
interactions and development of mature biofilms in vitro and in
vivo are cleared faster from the respiratory tract (Fig. 3) (Conover
et al. 2010; Serra et al. 2011). Thus, these results link B. pertussis
biofilms to increased respiratory tract survival.
In conclusion, the mouse models of Bordetella biofilm in-
fection satisfy the overall criteria for true biofilm infections.
Thesemodels have tremendous potential to enhance the under-
standing of host–pathogen interactions in the context of biofilm
infections.
IS THERE A ROLE FOR BIOFILMS IN HUMAN
INFECTIONS OF B. PERTUSSIS?
Although B. pertussis forms biofilms in the mouse respiratory
tract, the existence of B. pertussis biofilms and its role in B. per-
tussis life cycle in humans remains controversial. In 1912, the
6 FEMS Pathogens and Disease, 2016, Vol. 74, No. 1
Figure 4. Drawing of normal and infected ciliated epithelia lining the trachea. This drawing was reported in 1912, showing the appearance of infected epithelium of a
child dying in acute phase of pertussis. Picture taken from Mallory and Hornor (1912).
presence of ‘masses of minute bacilli packed between the cilia
of the lining epithelium’ and ‘in the secretion in the trachea
and bronchi’ in the lungs patients who died of whooping cough
was reported (Mallory andHornor 1912). The drawings presented
(Fig. 4) clearly showed large numbers of bacteria in the form
of aggregates or clusters. Approximately, a hundred years later,
Paddock et al. (2008) observed clusters and tangles of B. pertus-
sis on the cilia of columnar epithelial cells lining the trachea
and bronchioles in human infants who succumbed to pertus-
sis. Bordetella pertussis was also found adherent to ciliated cells
of human nasal explants in the form of microcolonies (Soane
et al. 2000). While these authors did not specifically classify the
various bacterial forms as biofilms, the structures observed re-
semble biofilms described by us on abiotic surfaces and in the
mouse nose and trachea (Conover et al. 2010; Serra et al. 2011).
Moreover, Bps polysaccharide, which is required for biofilm for-
mation, expressed at higher levels during in vitro biofilm growth
and colocalizes with biofilms formed on mouse tissues, is ex-
pressed during human infections as evidenced by the presence
of anti-Bps antibodies in pertussis-positive patients (Conover
et al. 2010). Colocalization of either Bps and/or eDNA with the
bacterial structures formed on human respiratory tissues will
allow classification of the observed structures on human tissues
as biofilms.
BIOFILMS, A POTENTIAL EXPLANATION
FOR PERTUSSIS VACCINE FAILURE AND
REEMERGENCE
Bordetella pertussis infection or immunization with whole cell
vaccines (wPV) confers long-term immunity against B. pertus-
sis reinfection. However, wPVs are highly reactogenic, and the
safety and compliance concerns associated with wPV were
the impetus for implementation of acellular pertussis vaccines
(aPV), for pediatric immunizations and adult boosters. Although
the mechanisms that lead to reemergence of pertussis are
likely multifactorial, lower vaccine efficacy and poor short-lived
vaccine-induced immunity are some explanations (Guiso 2009;
Mooi 2010; Higgs et al. 2012). In recent years, a rapid drop in pro-
tection and waning protective immunity following aPV vacci-
nation has been observed suggesting that aPVs do not gener-
ate long-term immunity (Klein et al. 2012; Witt et al. 2013). All
commercial aPVs are formulatedwith alum, an adjuvant that in-
duces Th2-type immune responses (Marrack, McKee and Munks
2009), while wPVs and prior infection induce Th1/Th17-type re-
sponses (Higgs et al. 2012; Ross et al. 2013). Accumulated evi-
dence suggests that this difference in polarization is at least
partly responsible for the incomplete protection mediated by
aPVs (Higgs et al. 2012; Ross et al. 2013). Thus, the majority
of recent therapeutic efforts are focused on the identification
of novel adjuvant and antigen combinations that will remodel
the aPV response towards a response similar to that induced
by wPV.
Another viable hypothesis for vaccine failure is that current
vaccines do not protect against the bacterial biofilm state. The
choice of the current aPV components is based on functional
studies conducted under planktonic growth conditions. In gen-
eral, B. pertussis vaccination studies do not evaluate coloniza-
tion of the mouse nose or trachea, organs where biofilms are
observed. Inclusion of biofilm-promoting factors or antigens ex-
pressed at higher levels during biofilm development may re-
sult in enhanced protection against biofilms thereby facilitat-
ing the clearance of the infection. Recent work addressed the
ability of biofilm-derived proteins to enhance B. pertussis clear-
ance (de Gouw et al. 2014). In this study, while vaccination
with biofilm-derived proteins reduced the number of bacteria
in the lungs of mice, the numbers of bacteria harvested were
still higher than those harvested from lungs of aPV-vaccinated
mice. Surprisingly, vaccination with biofilm-derived proteins or
aPV did not reduce bacterial numbers in the mouse nose. One
factor that contributes significantly to colonization of B. pertus-
sis in the mouse nose and trachea is Bps (Conover et al. 2010).
Bps is also (i) required for biofilm formation; (ii) colocalizes
with biofilms; (iii) functions as a nasal adhesin and (iv) resists
complement (Conover et al. 2010; Ganguly et al. 2014). Thus,
development of a Bps conjugate vaccine either alone or in com-
bination with aPVmay prevent bacterial colonization and estab-
lishment of biofilms in the nose and the trachea. In this context,
it is quite encouraging that vaccination of mice with a protein-
conjugated PNAG (a Bps homolog) vaccine reduced Acinetobacter
baumannii bacterial burden in the blood (Bentancor et al. 2012).
Additionally, adoptive transfer of anti-PNAG antibodies reduced
Staphylococcus aureus bacterial burden (Kelly-Quintos et al. 2006).
CONCLUSIONS
Less than a decade after the first description, biofilms in B.
bronchiseptica and B. pertussis are beginning to be recognized
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as important contributors to the pathogenesis of these organ-
isms. This emerging view is probably best reflected by the in-
creased pace of research on Bordetella biofilms. Several important
discoveries and concepts applicable not only to Bordetella spp.
but also in general to bacterial biofilms have resulted from these
studies: (i) bacterial biofilm formation is a developmental pro-
gram that proceeds by a number of complex and highly or-
dered regulatory steps involving extensive and stage-specific
changes in gene expression, (ii) eDNA plays a critical role in
the stability of biofilms formed on host organs, (iii) repres-
sion of flagella expression subsequent to initial attachment
stage is critical for the maturation of abiotic biofilms and
(iv) establishment of an animal model of biofilms that com-
plies well with the criteria established for bacterial biofilm
infections. The cellular processes of biofilm formation and
maintenance, and the various biofilm matrix components
have the potential to serve as targets for novel antimicrobials
and more efficient vaccines that will better control the entire
infectious cycle including colonization, persistence, disease pre-
sentation and transmission.
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